Expression of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma cells is downregulated upon inhibition of BRAF
Karolina Uranowska(Karl Landsteiner University of Health Sciences), Christine Häfner(Medical University of Vienna)
Cited by 17
Related Papers
Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia
|International Journal of Oncology|2015|16